Zoetis Inc. Class A Common Stock (1ZTS)
MTA
Closed
Oct 2, 2026
Day's Range
61.6052 wk Range
61.04Overview - 1ZTS - Zoetis Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
28.82B
P/E (Trailing)
‪11.41‬
PEG Ratio
‪4.59‬
Price / Sales (TTM)
‪2.65‬
Price / Book
‪9.22‬
EV / EBITDA
‪8.08‬
Profitability
Gross Margin
‪72.73%‬
Profit Margin
‪27.68%‬
Operating Margin
‪40.72%‬
Return on Assets
‪15.35%‬
Return on Equity
‪64.91%‬
Ownership
Shares Outstanding
414.15M
Float
412.37M
Held by Insiders
‪0.16%‬
Held by Institutions
‪99.99%‬
Price stats
Beta
‪0.72‬
50-Day Avg
‪64.97‬
200-Day Avg
‪85.20‬
Dividends
Payout Ratio
‪33.61%‬
Frequency
Quarterly
Market Cap - 1ZTS - Zoetis Inc. Class A Common Stock
Peers - 1ZTS - Zoetis Inc. Class A Common Stock
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1ZTSMTAZoetis Inc. Class A Common Stock48.46BMarket Cap-99.48%52-week change11.41P/E (Trailing)‪27.68%‬Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+19.49%52-week change24.81P/E (Trailing)‪11.21%‬Profit Margin
- 1GALDMTAGalderma Group AG41.32BMarket Cap+15.70%52-week change53.11P/E (Trailing)‪14.57%‬Profit Margin
- 1NBIXMTANeurocrine Biosciences, Inc.12.55BMarket Cap+2.03%52-week change20.07P/E (Trailing)‪20.91%‬Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+46.86%52-week change-5.09P/E (Trailing)‪-2.78%‬Profit Margin
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+36.40%52-week change117.09P/E (Trailing)‪4.51%‬Profit Margin
- 1LNTHMTALantheus Holdings Inc.3.88BMarket Cap+49.76%52-week change23.84P/E (Trailing)‪17.69%‬Profit Margin
Profile Summary - 1ZTS - Zoetis Inc. Class A Common Stock
About
Zoetis Inc. Class A Common Stock represents Zoetis, a global animal health company focused on medicines, vaccines, diagnostics, and related technologies for pets and livestock. Zoetis develops and markets products used by veterinarians, livestock producers, and pet owners across companion animals such as dogs, cats,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
